Growth Metrics

Standard Biotools (LAB) Cash from Investing Activities (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Standard Biotools 448.37 Mn -6.80 Mn 11.31 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2,476.74%
Dec 31, 2025 -20.34%
Sep 30, 2025 -124.29%
Jun 30, 2025 88.07%
Mar 31, 2025 -43.15%
Dec 31, 2024 183.30%
Sep 30, 2024 -161.45%
Jun 30, 2024 -84.20%
Mar 31, 2024 2,524.91%
Dec 31, 2023 73.73%
Sep 30, 2023 -224.42%
Jun 30, 2023 -7.02%
Mar 31, 2023 7.23%
Dec 31, 2022 274.86%
Sep 30, 2022 107.77%
Jun 30, 2022 -15,826.27%
Sep 30, 2021 -18.76%
Jun 30, 2021 -84.75%
Mar 31, 2021 -498.91%
Dec 31, 2020 -106.22%
Sep 30, 2020 30.47%
Jun 30, 2020 -42.00%
Mar 31, 2020 3,268.78%
Dec 31, 2019 -108.41%
Sep 30, 2019 118.43%
Jun 30, 2019 -264.27%
Mar 31, 2019 -51,252.63%
Dec 31, 2018 -102.37%
Sep 30, 2018 -80.90%
Jun 30, 2018 1,696.58%
Mar 31, 2018 93.22%
Dec 31, 2017 -965.85%
Sep 30, 2017 -87.52%
Jun 30, 2017 -79.49%
Mar 31, 2017 26.95%
Dec 31, 2016 40.36%
Sep 30, 2016 3,263.36%
Jun 30, 2016 -98.62%
Mar 31, 2016 337.74%
Dec 31, 2015 -72.61%
Sep 30, 2015 357.95%
Jun 30, 2015 -168.08%
Mar 31, 2015 78.18%
Dec 31, 2014 243.02%
Sep 30, 2014 93.29%
Jun 30, 2014 51.45%
Mar 31, 2014 -1,360.59%
Dec 31, 2013 179.75%
Sep 30, 2013 56.18%
Jun 30, 2013 -1,248.98%
Mar 31, 2013 198.04%
Dec 31, 2012 -146.20%
Sep 30, 2012 -19.71%
Jun 30, 2012 44.11%
Mar 31, 2012 -7.83%
Dec 31, 2011 1.41%
Sep 30, 2011 114.87%
Jun 30, 2011 -48.80%
Mar 31, 2011 -6,513.47%
Dec 31, 2010 29.24%